PROLONGATION OF PRIMATE CARDIAC ALLOGRAFT SURVIVAL BY TREATMENT WITH ANTI-CD40 LIGAND (CD154) ANTIBODY1-Reference-Cited by-同舟云学术

PROLONGATION OF PRIMATE CARDIAC ALLOGRAFT SURVIVAL BY TREATMENT WITH ANTI-CD40 LIGAND (CD154) ANTIBODY1

Published:1999-12 Issue:11 Volume:68 Page:1800-1805
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Pierson Richard N.,Chang Andrew C.,Blum Matthew G.,Blair Kelly S.A.,Scott Margie A.,Atkinson James B.,Collins Brendan J.,Zhang Jian-Ping,Thomas David W.,Burkly Linda C.,Miller Geraldine G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. Molecular and biological characterization of a murine ligand for CD40

2. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).

3. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation

4. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

5. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to Immunomodulation for Solid Organ Transplantation;Annual Review of Medicine;2024-01-29

2. Animal Models of Transplantation;Reference Module in Life Sciences;2024

3. TNX-1500, a crystallizable fragment–modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival;American Journal of Transplantation;2023-08

4. Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation;The Journal of Thoracic and Cardiovascular Surgery;2023-05

5. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation;Transplantation;2022-12-23